Background: The goal directed hemodynamic therapy is an approach focused on the use of cardiac output and related parameters as end-points for fluids and drugs to optimize tissue perfusion and oxygen delivery. Primary aim: To determine the effects of intraoperative goal directed hemodynamic therapy on postoperative complications rates. Methods: A meta-analysis was carried out of the effects of goal directed hemodynamic therapy in adult noncardiac surgery on postoperative complications and mortality using Preferred Reporting Items for Systematic Reviews and Meta-Analyses methodology. A systematic search was performed in Medline PubMed, Embase, and the Cochrane Library (last update, October 2014). Inclusion criteria were randomized clinical trials in which intraoperative goal directed hemodynamic therapy was compared to conventional fluid management in noncardiac surgery. Exclusion criteria were trauma and pediatric surgery studies and that using pulmonary artery catheter. End-points were postoperative complications (primary) and mortality (secondary). Those studies that fulfilled the entry criteria were examined in full and subjected to quantifiable analysis, predefined subgroup analysis (stratified by type of monitor, therapy, and hemodynamic goal), and predefined sensitivity analysis. * Corresponding author. E-mail: ripo542@gmail.com (J. Ripollés). 
Introduction
The perioperative management of high-risk surgical patients continues to be a challenge for the anesthesiologists. Despite advances in perioperative management, the incidence of serious complications after major surgery remains high.
1,2 A decrease in perioperative oxygen transport is closely related to the development of organ failure and death. 3 It has also been demonstrated that a large high-risk surgical population accounts for 12.5% of surgical procedures and for more than 80% of deaths. 4 Surgical patients can be classified as high risk based on surgical factors or patient-related factors. 5 Goal directed hemodynamic therapy (GDHT) is based on the optimization of preload with the use of algorithms based on fluids, inotropes and/or vasopressors to achieve a certain goal in stroke volume (SV), cardiac index (CI), or oxygen delivery (DO 2 ). The ultimate goal of this optimization is to avoid fluid overload, tissue hypoperfusion, and hypoxia. 6 All the studies of perioperative hemodynamic optimization had the same starting point, fluid loading, and the same endpoint, achieving adequate DO 2 . However, clinical heterogeneity between studies of GDHT cannot be ignored, with regard to type of surgery, patient's characteristics, therapeutic goals, methods for achieving these goals and monitoring. The pulmonary arterial catheter (PAC) has been considered to be the ''gold standard'' for monitoring preload, afterload, contractility, and tissue oxygenation. The invasiveness and high rate of complications associated with this device render it as unsuitable for routine use in most cases. The use of minimally invasive monitoring has gained popularity in the past few years; these devices have been validated intraoperatively. Currently PAC is not recommended in most surgeries, and for this reason it was not analyzed in this meta-analysis. There are no data to support the practice of using central venous pressure to guide fluid therapy, 7 therefore, central venous pressure-guided fluid therapy was not included in analysis.
Yet there are no studies in which different algorithms or different objectives are compared. The best method for assessing tissue oxygenation and intravascular volume has not yet been defined. The present review was designed to update the published evidence and determine the effectiveness of intraoperative GDHT with regard to complications and mortality with different types of algorithms and monitors used.
Material and methods

Selection criteria
The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) methodology 8 was used to identify the studies, based on the following inclusion criteria: 1. Participants: Adult patients (over 18 years) undergoing elective noncardiac surgery were included. The studies were not limited in terms of surgical risk.
Types of intervention:
Intraoperative goal directed hemodynamic therapy: defined as hemodynamic monitoring that allows to perform a hemodynamic optimization algorithm based on the use of fluids, inotropes and/or vasopressors to achieve normal or supranormal hemodynamic values. GDHT guided by pulmonary artery catheter, transesophageal echocardiography or central venous pressure-guided GDHT were excluded.
Types of comparison:
The studies that were selected for analysis included those that compared GDHT with conventional fluid management (monitoring of blood pressure, electrocardiogram, heart rate, urine output and/or central venous pressure). 4. Results: RCTs reporting any of the following outcomes: postoperative complications and/or mortality. 5. Types of studies: RCTs where intraoperative GDHT was performed in adult patients scheduled for noncardiac major surgery. Only peer-reviewed manuscripts were included.
Sources of information
Following the PRISMA protocol 8 different search strategies (last updated in October 2014) were used to identify relevant studies that met inclusion criteria using EMBASE, MEDLINE and the Cochrane Library. There were no restrictions on the publication date or language. In addition to electronic searching, industry representatives were contacted for additional material. All identified review articles and evidence-based guidelines were hand-searched for additional references.
Search items
The search was conducted using the following key words: surgery, fluid, goal directed, end point, hemodynamic, target, goal and randomized controlled trial.
Study selection and data extraction
Two independent investigators assessed each title and abstract in order to discard any irrelevant RCTs and identify those potentially relevant. These RCTs were analyzed selecting those that met the inclusion criteria outlined above. RCT data extraction was performed by two different investigators and any discrepancy required further analysis and confirmation by a third investigator. The authors reviewed the data analysis in order to avoid errors in data transcription.
Assessment of risk of bias in included studies
Bias assessment risk was performed using the Cochrane risk of bias tool. From this tool, we used seven domains to assess the methodological quality of the studies included in the analysis.
Outcome variables
The primary outcome was the overall postoperative complications. The results were stratified according to the following variables: monitor utilized, therapy used to reach a hemodynamic goal and the hemodynamic goal. For the predefined subgroup analysis, studies were grouped:
( The secondary outcome was mortality.
Statistical analysis
Review manager (''Revman'') 10 for MAC (Cochrane collaboration, Oxford, UK) was used for statistical analysis. Meta-analysis was carried out using the Mantel---Haenszel 
Results
Study selection
There were 14,160 references in electronic databases, of which 1003 were screened. Of those, 55 RCTs were analyzed and 24 of them were included for systematic review and meta-analysis, excluding those who did not meet the inclusion criteria. Finally a total of 29 RCTs were included 9---37 ; 5 RCTs were added by manual search. 2654 patients were included. Fig. 1 shows the flowchart used for item selection.
Assessment of risk of bias in individual studies
Bias risk was analyzed with the Cochrane tool. This was performed by two authors independently and we resolved any disparity by discussion and the involvement of a third person. We present the methodological quality in a summary table and a graph (Figs. 2 and 3) .
Characteristics of the studies included in the analysis
The selected articles describe the results of RCTs that evaluated the use of intraoperative GDHT in noncardiac elective surgery, and that included postoperative complications and/or mortality as outcome. The characteristics of the included RCTs are shown in Table 1 .
Primary results
Total complications
Analyzing the 29 RCTs, 26 describe the total associated complications 10---37 GDHT was associated with a significant reduction in overall complication compared with patients treated in the control group (RR: 0.70, 95% CI: 0.62---0.79, p < 0.001) (Fig. 4) . p < 0.001), and with a CI target, CI > 2.5 mL/min/m 2 (RR: 0.58, 95% CI: 0.44---0.76, p < 0.001), whereas in the subgroup that utilized measures of oxygen delivery and extraction methods no significant decrease was observed (Fig. 7) .
Mortality
No significant differences were found with regard to mortality (RR: 0.76, 95% CI: 0.45---1.28, p = 0.30) (Fig. 8) . Figure 4 Effect of GDHT in the protocol group vs control group on overall complications. has been conducted and described above. A funnel plot was drawn for the primary outcome comparison to explore the possibility of publication bias. The symmetry of the funnel plot was assessed visually and did not suggest publication bias (Fig. 9 ).
Sensitivity analysis, assessment risk of bias across studies and publication bias
Discussion
Numerous studies have reported differences between technologies, especially in their response to typical surgical interventions such as fluid and vasoactive drug administration. 38 The results obtained with one type of monitoring cannot be extrapolated to those obtained with other monitors. 39 RCTs using noninvasive monitors were limited both in number of patients studied and methodological quality. How minimal invasive cardiac output monitoring techniques can be used to guide individualized fluid management 40 needs to be sustained by validation studies that adhere to the proposed methodological considerations 41 as well as large-scale clinical outcome studies.
There is some evidence that SV maximization strategies could be harmful in aerobically fit patients by leading to volume overload, 25 and recent evidence suggests that this goal does not provide the benefits previously described. 42 However, the results of our meta-analysis show that this hemodynamic goal remains valid. The use of dynamic response parameters to volume may decrease the risk of volume overload. A CI > 2.5 mL/min/m 2 as hemodynamic target within algorithms in which fluids, vasopressors and inotropes are used avoid the risk of hypotension due to decreased vasomotor tone. The use of inotropes increases the CO in situations where the patient is nonresponsive to the volume and does not present a reduced vasomotor tone. Inotropic support with dobutamine can result in changes in microvascular flow related to direct effects on the microcirculation as well as global CO. 43 With the exception of ScvO 2 , that was only evaluated in one RCT, 19 and was not associated with better outcomes, this meta-analysis has not been able to detect significant differences between subgroups. Therefore it seems reasonable to adapt GDHT to risk patient, type of surgery as well as its duration 44 as recommended by recent European Society of Anaesthesiology guidelines. 45 A multicenter observational trial in patients with intraabdominal surgery found that low ScvO 2 was associated with an increased risk of postoperative complications in high-risk surgery. In this trial, the optimal value of mean ScvO 2 to discriminate between patients who did or did not develop complications was 73% (sensitivity 72%, specificity 61%) 46 One of the major limitations of venous oximetry is that, as a global marker of demand-supply balance, it does not reflect organ-specific malperfusion. Whether ScvO 2 monitoring improves outcomes in surgical patients remains to be proven in large RCTs.
Unlike our results, a recent meta-analysis has shown a significant benefit of GDHT in patients receiving fluids and inotropes in order to achieve supraphysiological targets for oxygen delivery in high-risk patients. 47 This meta-analysis was unable to demonstrate a significant reduction in mortality. There are a number of reasons to explain why the control mortality may have decreased over time. These include: (1) better overall care thus decreasing mortality for similar patients; (2) clinicians' awareness, learning from previous early published studies and therefore drifting their practice toward lower risk groups; (3) improvement in technology, that has become less invasive and therefore, gaining more credibility. 48 Another reason for this may be that the most recent studies are not powered to assess mortality; in earlier studies, mortality was considered the most relevant endpoint, but this has changed to Figure 6 Effect of GDHT in the protocol group vs control group on overall complications grouped by therapy.
length of stay and morbidity endpoints with less high-risk patient group, and as a result, have very low or no mortality. However, a reduction in mortality associated with GDHT was demonstrated in groups of extremely high-risk patients (baseline mortality rate of >20%) 49 as well as with long-term follow-up. 50 Unlike previous meta-analysis, we have not included those studies in which PAC was used, since these studies were published over 10 years, and do not reflect current practice. Grocott et al. meta-analysis 51 included 31 studies with 5292 participants. The results are dominated by a single large RCT with a weight of more than 60% of the overall population in which PAC was used. 52 The present meta-analysis confirms that the use of minimally invasive monitoring is effective and reduces postoperative complications. Postsurgical complications have a dramatic Figure 7 Effect of GDHT in the protocol group vs control group on overall complications grouped by hemodynamic goal. (SV, stroke volume; CI, cardiac index, SVV, stroke volume variation; PPV, pulse pressure variation, PVI ® , Pleth Variability Index).
impact on costs. Potential costs savings resulting from GDHT are substantial 53 and seem to be cost effective even with moderate clinical effect. 54 Particularly, ODM technology has been considered favorably by both the NHS Center for evidence-based purchasing in the United Kingdom and United States Agency for Healthcare Research and Quality. 55, 56 
Research implications
More studies in which different types of monitoring and different types of algorithms and hemodynamic therapies are compared in patients with different risk in order to achieve optimal hemodynamic goals are needed. In addition, outcome report should be standardized. In this regard, 23   20  30  29  64  54  68  17  40  42  30  60  41  20  121  20  89  71  40  74  51  37  36  10  30  32  30  40   1196   20  29  28  64  54  67  16  40  44  30  50  41  17  120  20  90  71  40  75  50  37  26  10  30  40 Figure 8 Effect of GDHT in the protocol group vs control group on mortality.
recommendations for the evaluation and standardization of perioperative complications have been recently published. 57 In summary, more studies are needed to demonstrate a significant reduction in mortality associated with GDHT.
Weaknesses in study
The study by Mayer et al. 22 has been under investigation for ethical reasons, the manuscript has not been withdrawn and remains part of the scientific record at the time we searched the literature. To verify potential biases in our results, both the primary and the secondary outcome were re-examined without including the Mayer et al. 22 manuscript and no differences were found.
Many trials were single center trials and only one has investigated more than 100 patients per group. 19 Differences in methodological quality may cause heterogeneity. Smaller studies tend to be conducted and analyzed with less methodological rigor than larger studies, and trials of lower quality also tend to show larger intervention effects.
The major limitation of our analysis is that overall complications were analyzed, regardless of the severity of these and their impact on length of stay and/or mortality. Furthermore, the use of different surgical interventions, different monitoring systems and algorithms adds more heterogeneity to the analysis. Thus, study heterogeneity may reduce the precision of treatment effect estimates and reduce the generalizability of the results of this metaanalysis.
The present meta-analysis is based on studies that describe the incidence of postoperative complications. It has to be recognized that the reporting of complications is not consistent and that the definitions used can differ in type, definition and importance between studies, limiting the applicability of some of our findings.
Furthermore, and unlike previous meta-analysis, the present meta-analysis conducted a global analysis of total complications, without conducting an organ-specific 47, 58 or stratified by risk 49 analysis. Despite these limitations, the results are consistent in most subgroups analyzed and even when the analysis is restricted to those studies with higher quality.
Conclusions
The results of this meta-analysis show that the use of intraoperative GDHT with minimally invasive monitoring decreases postoperative complications in noncardiac surgery, although it was not possible to show a significant decrease in mortality rate. ScvO 2 monitoring was not able to decrease the frequency of complications.
Conflicts of interest
The authors declare no conflicts of interest.
Funding
This study had no funding. EAR group is a collaborative independent nonprofit group, endless external funding.
